Correspondence 0001214659-23-003910 from Biodexa Pharmaceuticals Plc (BDRX)
Biodexa Pharmaceuticals Plc
Date: March 16, 2023 · CIK: 0001643918 · Accession: 0001214659-23-003910
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270353
Letter
Midatech Pharma PLC
1 Caspian Point
Caspian Way
Cardiff, CF10 4DQ
United Kingdom
March 16, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Daniel Crawford
Re: Midatech Pharma PLC
Registration Statement on Form F-1 (File No. 333-270353)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Midatech Pharma PLC hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form F-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m., Eastern Time, on March 24, 2023, or as soon as practicable thereafter.
Please call Jason S. McCaffrey of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement.
Very truly yours,
MIDATECH PHARMA PLC
Show Raw Text
CORRESP
1
filename1.htm
Midatech Pharma PLC
1 Caspian Point
Caspian Way
Cardiff, CF10 4DQ
United Kingdom
March 16, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Daniel Crawford
Re: Midatech Pharma PLC
Registration Statement on Form F-1 (File No. 333-270353)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended, Midatech Pharma PLC hereby respectfully requests that the
Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form F-1 (the “Registration
Statement”) and declare the Registration Statement effective as of 4:00 p.m., Eastern Time, on March 24, 2023, or as soon as practicable
thereafter.
Please call Jason S. McCaffrey
of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding
the Registration Statement.
Very truly yours,
MIDATECH PHARMA PLC
By: /s/Stephen Stamp
Name:
Stephen Stamp
Title:
Chief Executive Officer & Chief Financial Officer
cc: Jason S. McCaffrey, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.